Goldman Sachs Group Inc Amphastar Pharmaceuticals, Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 356,250 shares of AMPH stock, worth $8.27 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
356,250
Previous 406,712
12.41%
Holding current value
$8.27 Million
Previous $11.8 Million
30.63%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding AMPH
# of Institutions
258Shares Held
33.1MCall Options Held
18.3KPut Options Held
12.6K-
Black Rock Inc. New York, NY5.94MShares$138 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$62.4 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$47.3 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$37.8 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$36.6 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.14B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...